ebomi
Colour theme
Sign in
Insider · CIK 0001257242

Durus Life Sciences Master Fund Ltd

CIK 0001257242 Name as filed on the most recent filing

Filed as Durus Life Sciences Master Fund Ltd (82)

2,121 transaction lines · from 82 filings · filed 2003-10-30 to 2004-11-19 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-28 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

2,121 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-28 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2002-12-12 P, Open-market purchase Allos Therapeutics IncALTH 3 lines 59,020, acquired Open Form 4 filing 0000902664-03-001549
2002-12-11 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 2 lines 49,159, acquired Open Form 4 filing 0000902664-03-001555
2002-12-11 P, Open-market purchase Aksys LtdAKSY 2 lines 108,434, acquired Open Form 4 filing 0000902664-03-001596
2002-12-11 P, Open-market purchase Allos Therapeutics IncALTH 2 lines 86,828, acquired Open Form 4 filing 0000902664-03-001549
2002-12-10 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 3 lines 153,447, acquired Open Form 4 filing 0000902664-03-001555
2002-12-10 P, Open-market purchase Aksys LtdAKSY 12,637, acquired Open Form 4 filing 0000902664-03-001596
2002-12-10 P, Open-market purchase Allos Therapeutics IncALTH 8,149, acquired Open Form 4 filing 0000902664-03-001549
2002-12-10 P, Open-market purchase Aksys LtdAKSY 7,963, acquired Open Form 4 filing 0000902664-03-001594
2002-12-09 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 2 lines 77,944, acquired Open Form 4 filing 0000902664-03-001555
2002-12-09 P, Open-market purchase Allos Therapeutics IncALTH 2 lines 61,795, acquired Open Form 4 filing 0000902664-03-001549
2002-12-09 P, Open-market purchase Aksys LtdAKSY 2 lines 92,520, acquired Open Form 4 filing 0000902664-03-001594
2002-12-06 P, Open-market purchase Allos Therapeutics IncALTH 2 lines 252,639, acquired Open Form 4 filing 0000902664-03-001549
2002-12-06 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 3 lines 102,663, acquired Open Form 4 filing 0000902664-03-001552
2002-12-06 P, Open-market purchase Aksys LtdAKSY 3 lines 52,504, acquired Open Form 4 filing 0000902664-03-001594
2002-12-05 P, Open-market purchase Allos Therapeutics IncALTH 3 lines 138,746, acquired Open Form 4 filing 0000902664-03-001549
2002-12-05 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 3 lines 112,575, acquired Open Form 4 filing 0000902664-03-001552
2002-12-05 P, Open-market purchase Aksys LtdAKSY 3 lines 279,441, acquired Open Form 4 filing 0000902664-03-001594
2002-12-04 S, Open-market sale Guilford Pharmaceuticals IncGLFD 106,711, disposed Open Form 4 filing 0000902664-03-001586
2002-12-04 P, Open-market purchase Allos Therapeutics IncALTH 2 lines 15,444, acquired Open Form 4 filing 0000902664-03-001549
2002-12-04 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 3 lines 82,924, acquired Open Form 4 filing 0000902664-03-001552
2002-12-04 P, Open-market purchase Aksys LtdAKSY 4 lines 112,904, acquired Open Form 4 filing 0000902664-03-001594
2002-12-03 S, Open-market sale Guilford Pharmaceuticals IncGLFD 62,196, disposed Open Form 4 filing 0000902664-03-001585
2002-12-03 S, Open-market sale Guilford Pharmaceuticals IncGLFD 6,824, disposed Open Form 4 filing 0000902664-03-001585

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 1,746
  • Open-market sale 375
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. DURUS LIFE SCIENCES MASTER FUND LTD, insider transactions. Retrieved 2026-08-28 from https://ebomi.com/insider/0001257242

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.